Crossmark

Investigational antibiotic cefepime/zidebactam as a therapeutic option for the treatment of an unyielding empyema in a paediatric patient caused by extensively drug-resistant Pseudomonas aeruginosa: a case report

Crossref DOI link: https://doi.org/10.1007/s10096-025-05106-8

Published Online: 2025-03-18

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Polati, Vishnu Rao https://orcid.org/0000-0002-8853-3308
Gattu, Santosh

Maturu, Venkata Nagarjuna

Prakasham, P. Swati

Maqsood, Maryam
License Information

Text and Data Mining valid from 2025-03-18

Version of Record valid from 2025-03-18
More Information

Article History

Received: 10 December 2024

Accepted: 10 March 2025

First Online: 18 March 2025

Declarations

:

: Cefepime/zidebactam treatment was initiated on compassionate grounds with due approval from CDSCO (Indian Drug Regulator) and also from hospital ethics committee.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below